Literature DB >> 21931004

Postdischarge complications after penetrating cardiac injury: a survivable injury with a high postdischarge complication rate.

Andrew L Tang1, Kenji Inaba, Bernardino C Branco, Matthew Oliver, Marko Bukur, Ali Salim, Peter Rhee, Joseph Herrold, Demetrios Demetriades.   

Abstract

HYPOTHESIS: A significant rate of postdischarge complications is associated with penetrating cardiac injuries.
DESIGN: Retrospective trauma registry review.
SETTING: Level I trauma center. PATIENTS: All patients sustaining penetrating cardiac injuries between January 2000 and June 2010. Patient demographics, clinical data, operative findings, outpatient follow-up, echocardiogram results, and outcomes were extracted. MAIN OUTCOME MEASURES: Cardiac-related complications and mortality.
RESULTS: During the 10.5-year study period, 406 of 40,706 trauma admissions (1.0%) sustained penetrating cardiac injury. One hundred nine (26.9%) survived to hospital discharge. The survivors were predominantly male (94.4%), with a mean (SD) age of 30.8 (11.7) years, and 74.3% sustained a stab wound. Signs of life were present on admission in 92.6%. Cardiac chambers involved were the right ventricle (45.9%), left ventricle (40.3%), right atrium (10.1%), left atrium (0.9%), and combined (2.8%). In-hospital follow-up was available for a mean (SD) of 11.0 (9.8) days (median, 8 days; range, 3-65 days) and outpatient follow-up was available in 46 patients (42.2%) for a mean (SD) of 1.9 (4.1) months (median, 0.9 months; range, 0.2-12 months). Abnormal echocardiograms demonstrated pericardial effusions (9), abnormal wall motion (8), decreased ejection fraction (<45%) (8), intramural thrombus (4), valve injury (4), cardiac enlargement (2), conduction abnormality (2), pseudoaneurysm (1), aneurysm (1), and septal defect (1). No operative intervention was required for the complications. The 1-year and 9-year survival rates were 97% and 88%, respectively.
CONCLUSIONS: Penetrating cardiac injuries remain highly lethal. A significant rate of cardiac complications can be expected and follow-up echocardiographic evaluation is warranted prior to discharge. The majority of these, however, can be managed without the need for surgical intervention.

Entities:  

Mesh:

Year:  2011        PMID: 21931004     DOI: 10.1001/archsurg.2011.226

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  6 in total

Review 1.  Precise survival time and physical activity after fatal left ventricle injury from sharp pointed weapon: a case report and a review of the literature.

Authors:  Angélique Franchi; Martin Kolopp; Henry Coudane; Laurent Martrille
Journal:  Int J Legal Med       Date:  2016-02-25       Impact factor: 2.686

2.  The Challenges of Using ICD codes to Perform a Comparative Analysis between Patients with Penetrating Cardiac Injuries who Underwent Non-Resuscitative Thoracotomy versus Sternotomy.

Authors:  Nikolay Bugaev; Janis L Breeze; Alyssa M Tutunjian; Horacio M Hojman; Eric J Mahoney; Benjamin P Johnson; Sandra S Arabian
Journal:  Perspect Health Inf Manag       Date:  2020-12-07

3.  How to mend a broken heart: a major stab wound of the left ventricle.

Authors:  Mari-Liis Kaljusto; Theis Tønnessen
Journal:  World J Emerg Surg       Date:  2012-05-28       Impact factor: 5.469

4.  Bullet embolization to the heart: A rare and confounding penetrating cardiac injury case report.

Authors:  Despoina Daskalaki; Hazim Hakmi; Adam Stright; Brian Mitzman; Evan R Mair; D'Andrea K Joseph; Gerard A Baltazar
Journal:  Int J Surg Case Rep       Date:  2020-06-25

5.  Successful surgical management of a through-and-through right atrial penetrating injury with a complete transaction of the right internal mammary artery: a case report.

Authors:  Ibrahim Albabtain; Ali Albargawi; Sami A Almalki; Mohammed Alnasser
Journal:  J Surg Case Rep       Date:  2021-01-09

6.  Traumatic aorto-pulmonary artery fistula: a case report.

Authors:  Ruchika Meel; Thumone Govindasamy; Ricardo Gonçalves
Journal:  Eur Heart J Case Rep       Date:  2019-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.